Last update :
28/04/2024
References   References 3773  
Type : Manufacturer

Research teams :
Authors :
Title : Ramicirumab (Cyramza®) - Summary of Product Characteristics
Reference : Eli Lilly 2014

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionRamucirumab Anticancer drug
Factors which affect stability Solvent Glucose 5% Induces Degradation
Stability in solutions Not specified Sodium chloride 0,9% mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Sodium chloride 0,9% mg/ml 25°C Not specified
4 Hour
Incompatible + Glucose 5%

  Mentions Légales